Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azocane and azonane derivatives and methods of treating hepatitis B infections

Azocane and azonane derivatives and methods of treating hepatitis B infections

US Patent 10537580 · Granted Jan 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of NLRP3 inflammasome2025
5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
6-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
Inhibitors of NLRP3 inflammasome2025
N-oxide inhibitors of NLRP3 inflammasome2024
Substituted aminopyridine compounds as EGFR inhibitors2024
Substituted aminopyridine compounds as EGFR inhibitors2024
N-oxide inhibitors of NLRP3 inflammasome2023
Dihydroorotate dehydrogenase inhibitors2023
Inhibitors of NLRP3 inflammasome2023
Inhibitors of NLRP3 inflammasome2023
Dihydroorotate dehydrogenase inhibitors2022